← Eichor
Study identifier: NCT06381934 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Validation of New Diagnostic Indices to Simplify Hyponatremia Therapy Assessment in Patients on Thiazide Diuretics

Condition: Thiazide Associated Hyponatremia  ·  Sponsor: University Hospital, Basel, Switzerland

PhaseNA
Planned participants136
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study is looking at two new parameters, aSID and ChU, to see if these can help physicians to distinguish between different causes of low sodium levels (hyponatremia) in Patients taking a medicament against high blood pressure (thiazide). Researchers also want to see if using these new parameters to decide on treatment works just as well, or better, than the current standard treatments.

This description comes directly from the study's public registry record.

Talk to the study team

Laura Potasso, Dr. med. sc.  ·  +41 61 328 58 76  ·  laura.potasso@usb.ch

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospital BaselBasel, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06381934